The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in < 7 minutes at the point of care.
The measurement of HbA1c allows physicians and pharmacists to monitor patients with diabetes, or as an aid to screen and identify those at risk for developing diabetes.
The LumiraDx HbA1c test is a smart, automated, highly portable solution designed to improve access and ease of use in community-based healthcare settings.
The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run.
The workflow process is comprised of a simple sample collection with a fingerstick lancet followed by step-by-step guidance of the Instrument to report a patient result in <7 minutes from sample application.
The LumiraDx HbA1c Test was evaluated at the European Reference Laboratory for Glycohaemoglobin (ERL) by Dr. Erna Lenters-Westra (Clinical Chemistry Department, Isala, Zwolle, The Netherlands). The aim of the evaluation was to assess the performance of fresh EDTA whole blood samples compared to values assigned using four IFCC and NGSP certified Secondary Reference Measurement Procedures (SRMPs). The method comparison results between the mean of the 4 SRMPs and the mean of the 2 LumiraDx Instruments can be found below.